Dysphagia Knowledge Hub — 吞嚥困難知識庫

Esophageal Dysphagia: Assessment and Management Guide for Clinicians

Esophageal dysphagia — the sensation that food “sticks” in the chest or throat after swallowing is initiated — represents a distinct category of swallowing disorders that differs fundamentally from oropharyngeal dysphagia in its mechanisms, diagnostic approach, and treatment. While oropharyngeal dysphagia is usually the domain of speech-language pathologists and neurologists, esophageal dysphagia is primarily managed by gastroenterologists. This article provides a comprehensive clinical reference for assessment and management of esophageal dysphagia.

1. Distinguishing Esophageal from Oropharyngeal Dysphagia

1.1 Clinical differentiation

The first critical step is determining whether the patient’s dysphagia is originating from the oropharyngeal or the esophageal phase of swallowing. This can usually be accomplished through careful history:

Oropharyngeal features:

Esophageal features:

Patients will often point to where they feel the obstruction. Point-to-throat usually indicates oropharyngeal or upper esophageal, while point-to-chest indicates distal esophageal.

1.2 The “pointing test” caveat

Patients are only about 70% accurate in localizing their dysphagia. A distal esophageal lesion can project perceived obstruction to the neck because of the shared innervation and referred sensation. Any dysphagia referred to the neck that cannot be explained by oropharyngeal pathology should be investigated with upper endoscopy.

2. Classification: Mechanical vs Motor

Esophageal dysphagia is traditionally classified into two broad categories based on underlying mechanism:

2.1 Mechanical (Structural) Dysphagia

Features suggesting mechanical obstruction:

Common mechanical causes:

2.2 Motor Dysphagia

Features suggesting motor (neuromuscular) dysfunction:

Common motor disorders:

2.3 The “solids vs solids and liquids” rule

A useful clinical rule: patients with mechanical obstruction typically have dysphagia only to solids (at least initially), while motor disorders produce dysphagia to both solids and liquids from the start. Progressive solid-only dysphagia suggests a structural lesion that may be enlarging (most concerning for malignancy); intermittent symptoms to both solids and liquids strongly suggest a motility disorder.

3. History-Taking Framework

A structured history is essential for narrowing the differential diagnosis before invasive testing.

3.1 Key questions

  1. When did symptoms begin?
    • Acute onset: consider foreign body, pill esophagitis, ring disimpaction
    • Gradual progressive: peptic stricture, malignancy
    • Long-standing intermittent: ring, motility disorder, EoE
  2. Solids, liquids, or both?
    • Solids only: likely mechanical
    • Both: likely motor
    • Progression from solids to liquids: suggests worsening mechanical obstruction
  3. Progressive or intermittent?
    • Progressive: malignancy until proven otherwise
    • Intermittent: Schatzki ring, EoE, motility disorder
  4. Where does food get stuck?
    • Neck: could be either (see pointing test caveat)
    • Chest: typically esophageal
  5. Associated symptoms?
    • Heartburn → peptic stricture
    • Food impaction → EoE, ring
    • Chest pain → spasm, achalasia
    • Weight loss → malignancy, severe achalasia
    • Regurgitation → achalasia, Zenker’s diverticulum
    • Aspiration pneumonia → achalasia, severe dysfunction
  6. Dietary pattern?
    • Cold foods trigger symptoms → esophageal spasm
    • Food impactions → EoE
    • “Dinner going down with difficulty” → achalasia
    • Foods needing to be washed down → any obstruction
  7. Past medical history?
    • Long-standing reflux → peptic stricture, Barrett’s
    • Atopy, asthma, food allergy → EoE
    • Scleroderma or Raynaud’s → scleroderma esophagus
    • Radiation to chest → post-radiation stricture
    • Prior foregut surgery → anastomotic stricture
  8. Medications?
    • Bisphosphonates, doxycycline, NSAIDs, iron, KCl → pill esophagitis
    • Chronic opioids → opioid-induced esophageal dysfunction
    • Calcium channel blockers → worsened reflux, LES relaxation
  9. Social history?
    • Alcohol and smoking → malignancy, GERD
    • Occupational exposures
    • Travel (parasitic causes in endemic areas, e.g., Chagas disease in South America → achalasia-like picture)

3.2 Red flags requiring urgent evaluation

These warrant urgent upper endoscopy to exclude malignancy.

4. Diagnostic Workup

4.1 Upper endoscopy (EGD) — first-line investigation

Upper endoscopy is the first investigation in nearly all patients with esophageal dysphagia. It allows direct visualization, biopsy, and often simultaneous treatment.

What EGD can identify:

Systematic biopsy protocol for EoE: Even with normal-appearing mucosa, obtain biopsies from the upper (proximal), middle, and lower (distal) esophagus — at least 2 from each level, totaling 6 biopsies. EoE can be present with normal-appearing mucosa, and biopsies are essential.

4.2 Barium esophagography

Barium studies have a complementary role to endoscopy. They excel at:

A timed barium esophagram is particularly useful for achalasia — measuring the barium column height at 1, 2, and 5 minutes after ingestion provides objective assessment of esophageal emptying.

4.3 High-resolution manometry (HRM)

HRM is the gold standard for diagnosing esophageal motility disorders. It uses a catheter with closely spaced pressure sensors (every 1 cm) to generate a color-coded pressure topography map of esophageal contractions.

The Chicago Classification v4.0 provides a standardized diagnostic framework:

Diagnosis Key HRM findings
Achalasia I Integrated relaxation pressure (IRP) >15 mmHg, 100% failed peristalsis, no panesophageal pressurization
Achalasia II IRP >15 mmHg, 100% failed peristalsis, panesophageal pressurization ≥20%
Achalasia III IRP >15 mmHg, ≥20% premature contractions
EGJ outflow obstruction IRP >15 mmHg but with evidence of peristalsis
Distal esophageal spasm Normal IRP, ≥20% premature contractions
Hypercontractile (jackhammer) Normal IRP, ≥20% hypercontractile swallows (DCI >8000 mmHg·s·cm)
Ineffective motility Normal IRP, ≥70% ineffective swallows
Absent contractility Normal IRP, 100% failed peristalsis, no achalasia criteria

4.4 Additional tests in specific situations

FLIP (Functional Lumen Imaging Probe): A balloon-based measurement of esophageal distensibility. Useful for:

pH testing or pH-impedance: When reflux is suspected as the underlying cause, particularly before considering fundoplication.

CT scan: For extrinsic compression, mediastinal lesions, malignancy staging.

Endoscopic ultrasound (EUS): For malignancy staging and submucosal lesions.

5. Major Disorders in Detail

5.1 Achalasia

Achalasia is a rare but important motility disorder characterized by failure of lower esophageal sphincter (LES) relaxation and absent esophageal peristalsis. Prevalence is approximately 10 per 100,000.

Pathophysiology: Loss of inhibitory neurons in the myenteric plexus, possibly autoimmune.

Clinical presentation:

Diagnosis:

Treatment options:

  1. Pneumatic dilation — graded balloon dilation, 80% initial success, often requires repeat
  2. Laparoscopic Heller myotomy with partial fundoplication — gold standard surgery, 90% success
  3. POEM (peroral endoscopic myotomy) — newer endoscopic approach, comparable efficacy to Heller, particularly good for Type III
  4. Botulinum toxin injection — symptomatic temporary relief, used in high-surgical-risk patients
  5. Calcium channel blockers or nitrates — minimal efficacy, last resort

5.2 Eosinophilic Esophagitis (EoE)

EoE has emerged as a major cause of dysphagia and food impaction, particularly in young men with atopic backgrounds. Prevalence has been rising dramatically and is now estimated at 50 per 100,000.

Pathophysiology: Chronic allergic/immune-mediated inflammation driven by food antigens (and possibly aeroallergens).

Clinical presentation:

Diagnosis:

Treatment (the “3 Ds”):

  1. Diet: elemental diet, empirical elimination (6-food elimination or less restrictive), targeted elimination based on allergy testing
  2. Drugs: topical corticosteroids (swallowed budesonide or fluticasone), PPI (~40% response), biologics (dupilumab approved for EoE)
  3. Dilation: esophageal dilation for strictures, usually after medical therapy

5.3 Peptic Stricture

Peptic strictures result from chronic acid exposure causing fibrosis in the distal esophagus.

Clinical presentation:

Management:

5.4 Schatzki Ring

A mucosal ring at the squamocolumnar junction, often associated with a small hiatal hernia. Common in middle-aged adults.

Clinical presentation:

Management:

5.5 Esophageal Cancer

Esophageal cancer is a critical diagnosis not to miss. Two main types:

Squamous cell carcinoma:

Adenocarcinoma:

Warning signs for esophageal cancer:

Any patient over 50 with new dysphagia should undergo EGD promptly to exclude cancer.

5.6 Pill Esophagitis

Medications with prolonged mucosal contact can cause severe focal esophagitis. Most commonly:

Presentation: Sudden-onset retrosternal pain, odynophagia, dysphagia. History usually reveals recent pill taken with inadequate water or in a supine position.

Management:

6. Management Principles

6.1 Mechanical dysphagia

6.2 Motor disorders

6.3 Functional dysphagia

Rome IV criteria define functional dysphagia: dysphagia without identifiable structural, inflammatory, or motor abnormality. Management is challenging:

6.4 Nutritional support

Most patients with esophageal dysphagia maintain adequate oral intake, but severe cases may need:

7. Special Populations

7.1 Elderly patients

7.2 Patients with scleroderma

7.3 HIV patients

7.4 Post-surgical patients

8. Complications of Esophageal Dysphagia

8.1 Aspiration

While less common than in oropharyngeal dysphagia, esophageal causes can result in aspiration when:

8.2 Malnutrition and weight loss

Progressive restriction of diet due to dysphagia eventually leads to weight loss and nutritional deficiency. This should prompt accelerated investigation and treatment.

8.3 Food impaction

Requires urgent endoscopic removal. After successful removal:

8.4 Perforation

Instrumental (during EGD or dilation) or spontaneous (Boerhaave syndrome after forceful vomiting). Life-threatening; requires immediate surgical consultation.

9. Emerging Areas

9.1 Expanding role of FLIP

Functional lumen imaging probe provides novel insights into esophageal distensibility and is increasingly used in:

9.2 POEM and beyond

Peroral endoscopic myotomy has revolutionized achalasia treatment. New applications include:

9.3 Biologics for EoE

Dupilumab was approved for EoE in 2022, targeting IL-4 and IL-13 pathway. Other biologics (benralizumab, etc.) are in development. This represents a paradigm shift from dietary and topical steroid management.

9.4 Microbiome research

Emerging evidence that esophageal microbiome alterations contribute to EoE and possibly other motility disorders. Future therapeutic implications remain to be determined.

10. Clinical Approach Summary

A practical stepwise approach for the clinician evaluating a patient with suspected esophageal dysphagia:

  1. Careful history — oropharyngeal vs esophageal, mechanical vs motor
  2. Red flag assessment — weight loss, anemia, progressive symptoms
  3. Upper endoscopy first — diagnostic and often therapeutic
  4. Biopsies at EGD — always include EoE biopsies in dysphagia workup
  5. Barium swallow — complementary, especially for suspected motility disorders
  6. HRM — for motor disorders, Chicago Classification v4.0
  7. Targeted treatment — dilation for mechanical, medical or procedural for motor
  8. Follow-up — confirm symptom resolution, monitor for complications, prevent recurrence
  9. Refer when needed — surgery, advanced endoscopy, thoracic or bariatric specialists

Conclusion

Esophageal dysphagia is a common presenting problem with a wide differential diagnosis ranging from benign and easily treatable conditions (rings, peptic strictures) to life-threatening malignancies. A systematic clinical approach combining thorough history, endoscopy, functional testing, and appropriately chosen interventions can resolve symptoms in the vast majority of patients. The last decade has seen significant advances in diagnosis (Chicago Classification, FLIP) and treatment (POEM, biologics for EoE), and the field continues to evolve rapidly. Clinicians should maintain an organized diagnostic framework, recognize red flags warranting urgent evaluation, and collaborate with gastroenterology, thoracic surgery, and nutrition services when managing complex cases. The patient’s symptom burden — often profoundly impacting quality of life — deserves rigorous attention and evidence-based care.

This clinical reference is for educational purposes and does not replace individualized patient evaluation and management by qualified physicians. Guidelines and best practices evolve; consult current society recommendations (AGA, ACG, ASGE) for up-to-date management protocols.

This site is open source. Improve this page.